LLY Eli Lilly & Co

Pharmaceutical Preparations · NYSE · SEC EDGAR official

Market Value*

$807.89B

Revenue (FY)

$65.18B 2025-12-31

Net Income (FY)

$20.64B

P/E (float-based)

39.1

1990 United States Supreme Court case.

Financial History annual

Interactive chart · SEC EDGAR annual filings (10-K / 20-F) · enable JavaScript if blank

*Market value = public float disclosed in latest 10-K filing · CIK 59478 · SEC filings · revenue ranking · home